导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.24% | 648/1050 |
| 近一周 | -1.99% | 460/1104 |
| 近一月 | -3.51% | 469/1102 |
| 近一季 | -3.74% | 521/1092 |
| 近半年 | -3.29% | 562/1070 |
| 近一年 | -0.27% | 600/1018 |
| 近两年 | 36.99% | 627/926 |
| 近三年 | 1.45% | 671/833 |
| 成立以来 | 60.77% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.36% 737/1070 |
13.08% 497/1101 |
- - |
- - |
| 2025 | 24.18% 597/1065 |
4.60% 436/1014 |
3.50% 394/1038 |
14.97% 742/1050 |
-0.22% 467/1065 |
| 2024 | -10.94% 782/1011 |
-4.04% 537/960 |
-5.65% 669/983 |
11.20% 529/991 |
-11.55% 940/1011 |
| 2023 | -6.94% 250/952 |
7.08% 220/880 |
-3.04% 379/895 |
-4.70% 285/915 |
-5.95% 603/952 |
| 2022 | -25.58% 512/867 |
-14.19% 223/773 |
5.73% 477/806 |
-13.81% 504/845 |
-4.83% 644/867 |
| 2021 | 22.21% 145/740 |
0.74% 122/580 |
11.40% 321/659 |
5.42% 122/704 |
3.30% 289/740 |
| 2020 | 46.77% 256/554 |
1.60% 121/419 |
21.43% 263/466 |
10.28% 248/517 |
7.88% 394/554 |
| 2019 | 41.19% 210/410 |
23.21% 829/1146 |
-1.20% 456/1228 |
4.78% 204/390 |
10.69% 144/410 |
| 2018 | - - |
- - |
-1.87% 119/990 |
-8.70% 687/1000 |
-8.22% 163/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 海富通量化前锋股票C VS. 东吴新产业精选股票A(580008) |